4 Einträge gefunden

1. Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

   1. Striefler, Jana Käthe
   2. Riess, Hanno
   3. Lohneis, Philipp
   4. Bischoff, Sven
   5. Kurreck, Annika
   6. Modest, Dominik Paul
   7. Bahra, Marcus

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials

   1. Kurreck, Annika
   2. Weckwerth, Johanna
   3. Modest, Dominik P
   4. Striefler, Jana K
   5. Bahra, Marcus
   6. Bischoff, Sven
   7. Pelzer, Uwe

   2021 - Forschungsinformationssystem des UKE
3. TP53 mutations predict sensitivity to adjuvant gemcitabine in patients with pancreatic ductal adenocarcinoma: next-generation sequencing results from the CONKO-001 trial

   1. Sinn, Marianne
   2. Sinn, Bruno V
   3. Treue, Denise
   4. Keilholz, Ulrich
   5. Damm, Frederik
   6. Schmuck, Rosa Bianca
   7. Lohneis, Philipp

   2020 - Forschungsinformationssystem des UKE
4. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.

   1. Sehouli, Jalid
   2. Richter, R
   3. Braicu, Elena Ioana
   4. Bühling, Kai J.
   5. Bahra, Marcus
   6. Neuhaus, Peter
   7. Lichtenegger, Werner

   2010 - Forschungsinformationssystem des UKE